遺伝子導入技術の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2247)
◆英語タイトル:Global Gene Delivery Technologies Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2247
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、遺伝子導入技術の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(生物学的、化学的、物理的)、用途別市場規模(遺伝子治療、細胞治療、ワクチン、研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・遺伝子導入技術の市場動向
・企業の競争状況、市場シェア
・遺伝子導入技術の種類別市場規模(生物学的、化学的、物理的)
・遺伝子導入技術の用途別市場規模(遺伝子治療、細胞治療、ワクチン、研究所)
・遺伝子導入技術の北米市場規模2016-2027(アメリカ、カナダ)
・遺伝子導入技術の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・遺伝子導入技術のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・遺伝子導入技術の中南米市場規模2016-2027(メキシコ、ブラジル)
・遺伝子導入技術の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Thermo Fisher Scientific, Inc.、QIAGEN、Horizon Discovery Group Co.、OriGene Technologies, Inc.、Oxford Biomedica、SignaGen Laboratories、Vectalys、Takara Bio Inc.、Bio-Rad Laboratories, Inc.、System Biosciences llc、Promega Corporation、Hoffmann-La Roche AG、Sirion-Biotech GmbH、Catalent Inc.、The Beijing Genomics Institute、LifeTech、Berry Genomics、Da An Gene)
・結論
【レポートの概要】

Gene delivery uses physical, chemical, or viral means to introduce genetic material into cells, thereby amplifying or enhancing their natural functions and harnessing their full therapeutic potential. These techniques use relatively aggressive means to disrupt the cell membrane (from electrical currents to surface charged lipids) and introduce macromolecular cargoes into cells, thereby triggering directed cytoplasmic events.

Market Analysis and Insights: Global Gene Delivery Technologies Market
The global Gene Delivery Technologies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Delivery Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Delivery Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Delivery Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Delivery Technologies market.

Global Gene Delivery Technologies Scope and Market Size
Gene Delivery Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Delivery Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biological
Chemical
Physical

Segment by Application
Gene Therapy
Cell Therapy
Vaccines
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
QIAGEN
Horizon Discovery Group Co.
OriGene Technologies, Inc.
Oxford Biomedica
SignaGen Laboratories
Vectalys
Takara Bio Inc.
Bio-Rad Laboratories, Inc.
System Biosciences llc
Promega Corporation
Hoffmann-La Roche AG
Sirion-Biotech GmbH
Catalent Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biological
1.2.3 Chemical
1.2.4 Physical
1.3 Market by Application
1.3.1 Global Gene Delivery Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Gene Therapy
1.3.3 Cell Therapy
1.3.4 Vaccines
1.3.5 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Delivery Technologies Market Perspective (2016-2027)
2.2 Gene Delivery Technologies Growth Trends by Regions
2.2.1 Gene Delivery Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Delivery Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Gene Delivery Technologies Forecasted Market Size by Regions (2022-2027)
2.3 Gene Delivery Technologies Industry Dynamic
2.3.1 Gene Delivery Technologies Market Trends
2.3.2 Gene Delivery Technologies Market Drivers
2.3.3 Gene Delivery Technologies Market Challenges
2.3.4 Gene Delivery Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery Technologies Players by Revenue
3.1.1 Global Top Gene Delivery Technologies Players by Revenue (2016-2021)
3.1.2 Global Gene Delivery Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Gene Delivery Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Delivery Technologies Revenue
3.4 Global Gene Delivery Technologies Market Concentration Ratio
3.4.1 Global Gene Delivery Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery Technologies Revenue in 2020
3.5 Gene Delivery Technologies Key Players Head office and Area Served
3.6 Key Players Gene Delivery Technologies Product Solution and Service
3.7 Date of Enter into Gene Delivery Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Delivery Technologies Breakdown Data by Type
4.1 Global Gene Delivery Technologies Historic Market Size by Type (2016-2021)
4.2 Global Gene Delivery Technologies Forecasted Market Size by Type (2022-2027)

5 Gene Delivery Technologies Breakdown Data by Application
5.1 Global Gene Delivery Technologies Historic Market Size by Application (2016-2021)
5.2 Global Gene Delivery Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Delivery Technologies Market Size (2016-2027)
6.2 North America Gene Delivery Technologies Market Size by Type
6.2.1 North America Gene Delivery Technologies Market Size by Type (2016-2021)
6.2.2 North America Gene Delivery Technologies Market Size by Type (2022-2027)
6.2.3 North America Gene Delivery Technologies Market Size by Type (2016-2027)
6.3 North America Gene Delivery Technologies Market Size by Application
6.3.1 North America Gene Delivery Technologies Market Size by Application (2016-2021)
6.3.2 North America Gene Delivery Technologies Market Size by Application (2022-2027)
6.3.3 North America Gene Delivery Technologies Market Size by Application (2016-2027)
6.4 North America Gene Delivery Technologies Market Size by Country
6.4.1 North America Gene Delivery Technologies Market Size by Country (2016-2021)
6.4.2 North America Gene Delivery Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene Delivery Technologies Market Size (2016-2027)
7.2 Europe Gene Delivery Technologies Market Size by Type
7.2.1 Europe Gene Delivery Technologies Market Size by Type (2016-2021)
7.2.2 Europe Gene Delivery Technologies Market Size by Type (2022-2027)
7.2.3 Europe Gene Delivery Technologies Market Size by Type (2016-2027)
7.3 Europe Gene Delivery Technologies Market Size by Application
7.3.1 Europe Gene Delivery Technologies Market Size by Application (2016-2021)
7.3.2 Europe Gene Delivery Technologies Market Size by Application (2022-2027)
7.3.3 Europe Gene Delivery Technologies Market Size by Application (2016-2027)
7.4 Europe Gene Delivery Technologies Market Size by Country
7.4.1 Europe Gene Delivery Technologies Market Size by Country (2016-2021)
7.4.2 Europe Gene Delivery Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery Technologies Market Size (2016-2027)
8.2 Asia-Pacific Gene Delivery Technologies Market Size by Type
8.2.1 Asia-Pacific Gene Delivery Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Delivery Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Delivery Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Delivery Technologies Market Size by Application
8.3.1 Asia-Pacific Gene Delivery Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Delivery Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Delivery Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Delivery Technologies Market Size by Region
8.4.1 Asia-Pacific Gene Delivery Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Delivery Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Delivery Technologies Market Size (2016-2027)
9.2 Latin America Gene Delivery Technologies Market Size by Type
9.2.1 Latin America Gene Delivery Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Gene Delivery Technologies Market Size by Type (2022-2027)
9.2.3 Latin America Gene Delivery Technologies Market Size by Type (2016-2027)
9.3 Latin America Gene Delivery Technologies Market Size by Application
9.3.1 Latin America Gene Delivery Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Gene Delivery Technologies Market Size by Application (2022-2027)
9.3.3 Latin America Gene Delivery Technologies Market Size by Application (2016-2027)
9.4 Latin America Gene Delivery Technologies Market Size by Country
9.4.1 Latin America Gene Delivery Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Gene Delivery Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery Technologies Market Size (2016-2027)
10.2 Middle East & Africa Gene Delivery Technologies Market Size by Type
10.2.1 Middle East & Africa Gene Delivery Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Delivery Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Delivery Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Delivery Technologies Market Size by Application
10.3.1 Middle East & Africa Gene Delivery Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Delivery Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Delivery Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Delivery Technologies Market Size by Country
10.4.1 Middle East & Africa Gene Delivery Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Delivery Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Gene Delivery Technologies Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Gene Delivery Technologies Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Gene Delivery Technologies Introduction
11.2.4 QIAGEN Revenue in Gene Delivery Technologies Business (2016-2021)
11.2.5 QIAGEN Recent Development
11.3 Horizon Discovery Group Co.
11.3.1 Horizon Discovery Group Co. Company Details
11.3.2 Horizon Discovery Group Co. Business Overview
11.3.3 Horizon Discovery Group Co. Gene Delivery Technologies Introduction
11.3.4 Horizon Discovery Group Co. Revenue in Gene Delivery Technologies Business (2016-2021)
11.3.5 Horizon Discovery Group Co. Recent Development
11.4 OriGene Technologies, Inc.
11.4.1 OriGene Technologies, Inc. Company Details
11.4.2 OriGene Technologies, Inc. Business Overview
11.4.3 OriGene Technologies, Inc. Gene Delivery Technologies Introduction
11.4.4 OriGene Technologies, Inc. Revenue in Gene Delivery Technologies Business (2016-2021)
11.4.5 OriGene Technologies, Inc. Recent Development
11.5 Oxford Biomedica
11.5.1 Oxford Biomedica Company Details
11.5.2 Oxford Biomedica Business Overview
11.5.3 Oxford Biomedica Gene Delivery Technologies Introduction
11.5.4 Oxford Biomedica Revenue in Gene Delivery Technologies Business (2016-2021)
11.5.5 Oxford Biomedica Recent Development
11.6 SignaGen Laboratories
11.6.1 SignaGen Laboratories Company Details
11.6.2 SignaGen Laboratories Business Overview
11.6.3 SignaGen Laboratories Gene Delivery Technologies Introduction
11.6.4 SignaGen Laboratories Revenue in Gene Delivery Technologies Business (2016-2021)
11.6.5 SignaGen Laboratories Recent Development
11.7 Vectalys
11.7.1 Vectalys Company Details
11.7.2 Vectalys Business Overview
11.7.3 Vectalys Gene Delivery Technologies Introduction
11.7.4 Vectalys Revenue in Gene Delivery Technologies Business (2016-2021)
11.7.5 Vectalys Recent Development
11.8 Takara Bio Inc.
11.8.1 Takara Bio Inc. Company Details
11.8.2 Takara Bio Inc. Business Overview
11.8.3 Takara Bio Inc. Gene Delivery Technologies Introduction
11.8.4 Takara Bio Inc. Revenue in Gene Delivery Technologies Business (2016-2021)
11.8.5 Takara Bio Inc. Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. Gene Delivery Technologies Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in Gene Delivery Technologies Business (2016-2021)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 System Biosciences llc
11.10.1 System Biosciences llc Company Details
11.10.2 System Biosciences llc Business Overview
11.10.3 System Biosciences llc Gene Delivery Technologies Introduction
11.10.4 System Biosciences llc Revenue in Gene Delivery Technologies Business (2016-2021)
11.10.5 System Biosciences llc Recent Development
11.11 Promega Corporation
11.11.1 Promega Corporation Company Details
11.11.2 Promega Corporation Business Overview
11.11.3 Promega Corporation Gene Delivery Technologies Introduction
11.11.4 Promega Corporation Revenue in Gene Delivery Technologies Business (2016-2021)
11.11.5 Promega Corporation Recent Development
11.12 Hoffmann-La Roche AG
11.12.1 Hoffmann-La Roche AG Company Details
11.12.2 Hoffmann-La Roche AG Business Overview
11.12.3 Hoffmann-La Roche AG Gene Delivery Technologies Introduction
11.12.4 Hoffmann-La Roche AG Revenue in Gene Delivery Technologies Business (2016-2021)
11.12.5 Hoffmann-La Roche AG Recent Development
11.13 Sirion-Biotech GmbH
11.13.1 Sirion-Biotech GmbH Company Details
11.13.2 Sirion-Biotech GmbH Business Overview
11.13.3 Sirion-Biotech GmbH Gene Delivery Technologies Introduction
11.13.4 Sirion-Biotech GmbH Revenue in Gene Delivery Technologies Business (2016-2021)
11.13.5 Sirion-Biotech GmbH Recent Development
11.14 Catalent Inc.
11.14.1 Catalent Inc. Company Details
11.14.2 Catalent Inc. Business Overview
11.14.3 Catalent Inc. Gene Delivery Technologies Introduction
11.14.4 Catalent Inc. Revenue in Gene Delivery Technologies Business (2016-2021)
11.14.5 Catalent Inc. Recent Development
11.15 The Beijing Genomics Institute
11.15.1 The Beijing Genomics Institute Company Details
11.15.2 The Beijing Genomics Institute Business Overview
11.15.3 The Beijing Genomics Institute Gene Delivery Technologies Introduction
11.15.4 The Beijing Genomics Institute Revenue in Gene Delivery Technologies Business (2016-2021)
11.15.5 The Beijing Genomics Institute Recent Development
11.16 LifeTech
11.16.1 LifeTech Company Details
11.16.2 LifeTech Business Overview
11.16.3 LifeTech Gene Delivery Technologies Introduction
11.16.4 LifeTech Revenue in Gene Delivery Technologies Business (2016-2021)
11.16.5 LifeTech Recent Development
11.17 Berry Genomics
11.17.1 Berry Genomics Company Details
11.17.2 Berry Genomics Business Overview
11.17.3 Berry Genomics Gene Delivery Technologies Introduction
11.17.4 Berry Genomics Revenue in Gene Delivery Technologies Business (2016-2021)
11.17.5 Berry Genomics Recent Development
11.18 Da An Gene
11.18.1 Da An Gene Company Details
11.18.2 Da An Gene Business Overview
11.18.3 Da An Gene Gene Delivery Technologies Introduction
11.18.4 Da An Gene Revenue in Gene Delivery Technologies Business (2016-2021)
11.18.5 Da An Gene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 遺伝子導入技術の世界市場規模・現状・予測2021年-2027年(Global Gene Delivery Technologies Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。